Cardiovascular risk reduction throughout GLP-1 receptor agonist and SGLT2 inhibitor modulation of epicardial fat
Gianluca Iacobellis, Marco Giorgio Baroni
Topics & Concepts
Adipose tissueMedicineInternal medicineEndocrinologyDiabetes mellitusType 2 diabetesEpicardial fatAtrial fibrillationObesityGlucagon-like peptide-1Coronary artery diseaseHeart failureRisk factorCardiologyPharmacologyCardiovascular Disease and AdiposityCardiovascular, Neuropeptides, and Oxidative Stress ResearchCardiovascular Function and Risk Factors